$4.64
0.112.43%
最終更新: Oct 20, 1:07 PM
$4.56
0.030.66%
Benzinga
Benzinga
Benzinga
火曜日, 10 20
Benzinga
© 2026 Benzinga | All Rights Reserved
Adicet Bio (ACET) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.79 | $-3.05 | $-3.08 | $-4.64 |
| Actual | $-1.99 | $-1.88 | $-2.94 | $-4.64 |
| Surprise | -11.2% | +38.4% | +4.55% | 0.00% |
| Revenue | ||||
| Estimate | — | — | $2.9M | — |
| Actual | $0 | $0 | — | — |
| Surprise | — | — | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.57 | $-1.54 | $-1.65 | $-1.54 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-1.99 | $-1.79 | -11.2 % |
| Q1 | May 13, 2026 | $-1.88 | $-3.05 | 38.4 % |
| Q4 | Mar 12, 2026 | $-2.94 | $-3.08 | 4.55 % |
| Q3 | Nov 5, 2025 | $-4.64 | $-4.64 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 12, 2026 | $0 | $2.86M | -100.0 % |
| Q2 | Aug 13, 2024 | $0 | $620.00K | -100.0 % |
| Q4 | Mar 19, 2024 | $0 | $620.00K | -100.0 % |
| Q3 | Nov 8, 2023 | $0 | $1.11M | -100.0 % |